S 2503
114th Congress
Senate
Health
Administrative law and regulatory procedures
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Government information and archives
Health technology, devices, supplies
Infectious and parasitic diseases
Preventing Superbugs and Protecting Patients Act
Introduced: February 4, 2016
Introduced by:
Murray, Patty
Democratic
· Washington
See on congress.gov
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 5, 2016
Placed on Senate Legislative Calendar under General Orders. Calendar No. 417.
Apr 5, 2016
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Feb 9, 2016
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Feb 4, 2016
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Feb 4, 2016
Introduced in Senate
Plain-English summary
Preventing Superbugs and Protecting Patients Act
(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to identify types of medical devices for which premarket notification must include proposed labeling, including validated instructions regarding cleaning, disinfection, and sterilization.
(Sec. 3) The FDA must issue final guidance regarding when a premarket notification is required for a modification to a medical device.
What's happening now
Placed on Senate Legislative Calendar under General Orders. Calendar No. 417.
Committees of jurisdiction
1